Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
// Cecilia A. Silva-Valenzuela 1, 2, 3 , Prerak T. Desai 1 , Roberto C. Molina-Quiroz 2, 4 , David Pezoa 2 , Yong Zhang 5 , Steffen Porwollik 1 , Ming Zhao 5 , Robert M. Hoffman 5, 6 , Inés Contreras 2 , Carlos A. Santiviago 2 , Michael McClelland 1 1 Department of Microbiology and Molecular Genetics, University of California, Irvine, CA, USA 2 Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile 3 Current address: Department of Molecular Biology and Microbiology, Tufts University, Boston, MA, USA 4 Current address: Center for Adaptation Genetics and Drug Resistance, Tufts University, Boston, MA, USA 5 AntiCancer, Inc., San Diego, CA, USA 6 Department of Surgery, University of California, San Diego, CA, USA Correspondence to: Carlos A. Santiviago, e-mail: csantiviago@ciq.uchile.cl Michael McClelland, e-mail: mmcclell@uci.edu Keywords: Salmonella Typhimurium, ethanolamine, high-throughput, mammary cancer, 4T1 Received: November 4, 2015 Accepted: April 10, 2016 Published: April 28, 2016 ABSTRACT Therapeutic attenuated strains of Salmonella Typhimurium target and eradicate tumors in mouse models. However, the mechanism of S . Typhimurium for tumor targeting is still poorly understood. We performed a high-throughput screening of single-gene deletion mutants of S . Typhimurium in an orthotopic, syngeneic murine mammary model of breast cancer. The mutants under selection in this system were classified into functional categories to identify bacterial processes involved in Salmonella accumulation within tumors. Niche-specific genes involved in preferential tumor colonization were identified and exemplars were confirmed by competitive infection assays. Our results show that the chemotaxis gene cheY and the motility genes motAB confer an advantage for colonization of Salmonella within orthotopic syngeneic breast tumors. In addition, eutC , a gene belonging to the ethanolamine metabolic pathway, also confers an advantage for Salmonella within tumors, perhaps by exploiting either ethanolamine or an alternative nutrient in the inflamed tumor environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Research works printed but not linked: 81
- Lambin, 2003, Modulation of cell death in the tumor microenvironment, Semin Radiat Oncol, 13, 31, 10.1053/srao.2003.50004 · DOI
- Zhao, 2014, Methods for the development of tumor-targeting bacteria, Expert Opin Drug Discov, 9, 741, 10.1517/17460441.2014.916270 · DOI
- Oelschlaeger, 2010, Bacteria as tumor therapeutics?, Bioengineered Bugs, 1, 146, 10.4161/bbug.1.2.11248 · DOI
- McCormick, 2010, Targeting tumors with- potential for therapy, Oncotarget, 1, 721, 10.18632/oncotarget.206 · DOI
- Chakravortty, 2012, serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactions, Virulence, 3, 377, 10.4161/viru.21087 · DOI
- Hoffman, 2012, Bugging tumors, Cancer Discov, 2, 588, 10.1158/2159-8290.CD-12-0227 · DOI
- Forbes, 2008, Tumor-targeting attenuatedTyphimurium accumulates within therapeutically-resistant microenvironments adjacent to tumor necrosis, J Am Coll Surgeons, 207, S101, 10.1016/j.jamcollsurg.2008.06.259 · doi:10.1016/j.jamcollsurg.2008.06.259
- Smooker, 2015, Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery, Vaccines (Basel), 3, 940, 10.3390/vaccines3040940 · DOI
- Blagosklonny, 2003, Matching targets for selective cancer therapy, Drug Discov Today, 8, 1104, 10.1016/S1359-6446(03)02806-X · DOI
- Blagosklonny, 2003, Tissue-selective therapy of cancer, Br J Cancer, 89, 1147, 10.1038/sj.bjc.6601256 · DOI
- Theys, 2007, Potential and limitations of bacterial-mediated cancer therapy, Front Biosci, 12, 3880, 10.2741/2357 · DOI
- Bermudes, 1997, Tumor-targetedas a novel anticancer vector, Cancer Res, 57, 4537
- Hoffman, 2011, Tumor-seekingamino acid auxotrophs, Curr Opin Biotechnol, 22, 917, 10.1016/j.copbio.2011.03.009 · DOI
- Forbes, 2011, In tumorsmigrate away from vasculature toward the transition zone and induce apoptosis, Cancer Gene Ther, 18, 457, 10.1038/cgt.2011.10 · DOI · Paper page
- Weiss, 2011, Biofilm formation byserovar Typhimurium colonizing solid tumours, Cell Microbiol, 13, 1223, 10.1111/j.1462-5822.2011.01612.x · DOI
- Forbes, 2006, Typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro, Biotechnol Bioeng, 94, 710, 10.1002/bit.20883 · DOI · Paper page
- Forbes, 2007, Typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis, Cancer Res, 67, 3201, 10.1158/0008-5472.CAN-06-2618 · DOI · Paper page
- Rescigno, 2010, Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity, Sci Transl Med, 2, 44ra57
- Weiss, 2008, Containment of tumor-colonizing bacteria by host neutrophils, Cancer Res, 68, 2952, 10.1158/0008-5472.CAN-07-2984 · DOI · Paper page
- Seipp, 2002, Phase I study of the intravenous administration of attenuatedTyphimurium to patients with metastatic melanoma, J Clin Oncol, 20, 142, 10.1200/JCO.2002.20.1.142 · DOI · Paper page
- Nemunaitis, 2001, A phase I trial of genetically modifiedTyphimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer, Hum Gene Ther, 12, 1594
- Hoffman, 2005, Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressingTyphimurium, Proc Natl Acad Sci USA, 102, 755, 10.1073/pnas.0408422102 · DOI · Paper page
- Hoffman, 2007, Monotherapy with a tumor-targeting mutant ofTyphimurium cures orthotopic metastatic mouse models of human prostate cancer, Proc Natl Acad Sci USA, 104, 10170, 10.1073/pnas.0703867104 · DOI · Paper page
- Hoffman, 2006, Targeted therapy with aTyphimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice, Cancer Res, 66, 7647, 10.1158/0008-5472.CAN-06-0716 · DOI · Paper page
- Zhao, 2012, Determination of the optimal route of administration ofTyphimurium A1-R to target breast cancer in nude mice, Anticancer Res, 32, 2501
- Zhao, 2015, Tumor-targetingTyphimurium A1-R arrests growth of breast-cancer brain metastasis, Oncotarget, 6, 2615, 10.18632/oncotarget.2811 · DOI
- Hoffman, 2012, Cancer-cell killing by engineeredimaged by multiphoton tomography in live mice, Anticancer Res, 32, 4331
- Zhao, 2010, Vessel destruction by tumor-targetingTyphimurium A1-R is enhanced by high tumor vascularity, Cell Cycle, 9, 4518, 10.4161/cc.9.22.13744 · DOI
- Hoffman, 2010, Monotherapy with a tumor-targeting mutant of. Typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer, J Surg Res, 164, 248, 10.1016/j.jss.2009.02.023 · DOI
- Hoffman, 2009, Efficacy of a genetically-modifiedTyphimurium in an orthotopic human pancreatic cancer in nude mice, Anticancer Res, 29, 1873
- Bouvet, 2013, Comparison of efficacy ofTyphimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells, Cell Cycle, 12, 2774, 10.4161/cc.25872 · DOI
- Tanaka, 2014, Efficacy ofTyphimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX), J Cell Biochem, 115, 1254, 10.1002/jcb.24769 · DOI
- Tanaka, 2014, Efficacy of tumor-targetingTyphimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models, Oncotarget, 5, 12346, 10.18632/oncotarget.2641 · DOI
- Zhao, 2014, Efficacy of tumor-targetingTyphimurium A1-R on nude mouse models of metastatic and disseminated human ovarian cancer, J Cell Biochem, 115, 1996
- Hoffman, 2015, Intraperitoneal administration of tumor-targetingTyphimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice, Oncotarget, 6, 11369, 10.18632/oncotarget.3607 · DOI
- Hoffman, 2014, Tumor-targetingTyphimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy, Cell Cycle, 13, 3958, 10.4161/15384101.2014.964115 · DOI · Paper page
- Mori, 2015, Tumor-targetingTyphimurium A1-R in combination with trastuzumab eradicates HER-2-positive cervical cancer cells in patient-derived mouse models, PLoS ONE, 10, e0120358, 10.1371/journal.pone.0120358 · doi:10.1371/journal.pone.0120358
- Hoffman, 2009, Cancer metastasis directly eradicated by targeted therapy with a modifiedTyphimurium, J Cell Biochem, 106, 992, 10.1002/jcb.22078 · DOI
- Hoffman, 2009, Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain ofTyphimurium, Cell Cycle, 8, 870, 10.4161/cc.8.6.7891 · DOI
- Tsuchiya, 2014, Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targetingTyphimurium A1-R, Oncotarget, 5, 12849, 10.18632/oncotarget.2561 · DOI
- Hoffman, 2010, Targeted therapy of spinal cord glioma with a genetically modifiedTyphimurium, Cell Prolif, 43, 41, 10.1111/j.1365-2184.2009.00652.x · DOI
- Hoffman, 2012, Inhibition and eradication of human glioma with tumor-targetingTyphimurium in an orthotopic nude-mouse model, Cell Cycle, 11, 628, 10.4161/cc.11.3.19116 · DOI
- McClelland, 2010, High-throughput screening foravirulent mutants that retain targeting of solid tumors, Cancer Res, 70, 2165, 10.1158/0008-5472.CAN-09-4005 · DOI
- Zhu, 2013, A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion, Cell Rep, 5, 493, 10.1016/j.celrep.2013.09.015 · DOI
- Hoffman, 2016, Tumor-targetingTyphimurium A1-R: an overview, Methods Mol Biol, 1409, 1, 10.1007/978-1-4939-3515-4_1 · DOI
- McClelland, 2009, Analysis of pools of targeteddeletion mutants identifies novel genes affecting fitness during competitive infection in mice, PLoS Pathog, 5, e1000477, 10.1371/journal.ppat.1000477 · DOI · Paper page
- Bogomolnaya, 2014, Defined single-gene and multi-gene deletion mutant collections insv Typhimurium, PLoS ONE, 9, e99820, 10.1371/journal.pone.0099820 · DOI · Paper page
- McClelland, 2015, Analysis of two complementary single-gene deletion mutant libraries ofTyphimurium in intraperitoneal infection of BALB/c mice, Front Microbiol, 6, 1455
- DeAtley, 2013, Novel determinants of intestinal colonization ofserotype Typhimurium identified in bovine enteric infection, Infect Immun, 81, 4311, 10.1128/IAI.00874-13 · DOI
- Vila, 2013, serovar Typhimurium skills to succeed in the host: virulence and regulation, Clin Microbiol Rev, 26, 308, 10.1128/CMR.00066-12 · DOI · Paper page
- Hensel, 2015, Take the tube: remodelling of the endosomal system by intracellular, Cell Microbiol, 17, 639, 10.1111/cmi.12441 · DOI
- Forbes, 2012, Motility is critical for effective distribution and accumulation of bacteria in tumor tissue, Integr Biol, 4, 165, 10.1039/c2ib00091a · DOI
- Forbes, 2015, Persistent enhancement of bacterial motility increases tumor penetration, Biotechnol Bioeng, 112, 2397, 10.1002/bit.25645 · DOI · Paper page
- Forbes, 2015, Trg-deficientcolonize quiescent tumor regions by exclusively penetrating or proliferating, J Control Release, 199, 180, 10.1016/j.jconrel.2014.12.014 · DOI
- Eisenbach, 2001, Acetylation of the response regulator, CheY, is involved in bacterial chemotaxis, Mol Microbiol, 40, 731, 10.1046/j.1365-2958.2001.02425.x · DOI
- Blair, 1998, Electrostatic interactions between rotor and stator in the bacterial flagellar motor, Proc Natl Acad Sci USA, 95, 6436, 10.1073/pnas.95.11.6436 · DOI · Paper page
- Galan, 2009, serovar Typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells, Infect Immun, 77, 2635, 10.1128/IAI.00077-09 · DOI · Paper page
- Galan, 1996, Molecular genetic bases ofentry into host cells, Mol Microbiol, 20, 263, 10.1111/j.1365-2958.1996.tb02615.x · DOI · Paper page
- Miller, 2008, interplay with host cells, Nat Rev Microbiol, 6, 53, 10.1038/nrmicro1788 · DOI · Paper page
- Bäumler, 2011, Intestinal inflammation allowsto use ethanolamine to compete with the microbiota, Proc Natl Acad Sci USA, 108, 17480, 10.1073/pnas.1107857108 · DOI · Paper page
- Bäumler, 2013, The dynamics of gut-associated microbial communities during inflammation, EMBO Rep, 14, 319, 10.1038/embor.2013.27 · DOI · Paper page
- Harshey, 2013, uses energy taxis to benefit from intestinal inflammation, PLoS Pathog, 9, e1003267, 10.1371/journal.ppat.1003267 · DOI · Paper page
- Bäumler, 2010, Gut inflammation provides a respiratory electron acceptor for, Nature, 467, 426, 10.1038/nature09415 · DOI · Paper page
- Rakoff-Nahoum, 2006, Why cancer and inflammation?, Yale J Biol Med, 79, 123
- Karin, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
- Bäumler, 2014, Comparative analysis ofgenomes identifies a metabolic network for escalating growth in the inflamed gut, mBio, 5, e00929
- Garsin, 2010, Ethanolamine utilization in bacterial pathogens: roles and regulation, Nat Rev Microbiol, 8, 290, 10.1038/nrmicro2334 · DOI · Paper page
- Andrews-Polymenis, 2014, Identification of novel factors involved in modulating motility ofserotype Typhimurium, PLoS ONE, 9, e111513, 10.1371/journal.pone.0111513 · doi:10.1371/journal.pone.0111513
- Weiss, 2009, Tumor invasion ofserovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-α, PLoS ONE, 4, e6692, 10.1371/journal.pone.0006692 · DOI · Paper page
- Martin, 2011, Enterohaemorrhagicgains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content, Environ Microbiol, 13, 365, 10.1111/j.1462-2920.2010.02334.x · DOI · Paper page
- Kendall, 2015, Ethanolamine signaling promotesniche recognition and adaptation during infection, PLoS Pathog, 11, e1005278, 10.1371/journal.ppat.1005278 · DOI
- al-Ramadi, 2014, -mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity, Cancer Immunol Immunother, 63, 587, 10.1007/s00262-014-1543-x · DOI
- Cao, 2014, A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity, PLoS ONE, 9, e85587, 10.1371/journal.pone.0085587 · DOI · Paper page
- Rowley, 2013, Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer, Cancer Immunol Res, 1, 123, 10.1158/2326-6066.CIR-13-0058 · DOI · Paper page
- Hoffman, 2014, Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging, Cell Cycle, 13, 953, 10.4161/cc.27818 · DOI
- Wanner, 2000, One-step inactivation of chromosomal genes inK-12 using PCR products, Proc Natl Acad Sci USA, 97, 6640, 10.1073/pnas.120163297 · DOI · Paper page
- Dudoit, 2005, Bioinformatics and computational biology solutions using R and Bioconductor, 397
- Olson, 2008, The RAST server: rapid annotations using subsystems technology, BMC Genomics, 9, 75, 10.1186/1471-2164-9-75 · DOI · Paper page
- Jin, 2012, VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors, Nucleic Acids Res, 40, D641, 10.1093/nar/gkr989 · DOI · Paper page
- McClelland, 2013, Evolutionary genomics ofsubspecies, mBio, 4, e00198
- Bader, 2014, Enrichment Map - a Cytoscape app to visualize and explore OMICs pathway enrichment results, F1000Res, 3, 141, 10.12688/f1000research.4536.1 · DOI · Paper page
Cited by
Identification of bacteria-derived HLA-bound peptides in melanoma
Kalaora, S., Nagler, A., Nejman, D., Alon, M., Barbolin, C., Barnea, E., Ketelaars, S. L. C., Cheng, K., Vervier, K., Shental, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03368-8 · Cited by 457
Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions
Kramer, M. G., Masner, M., Ferreira, F. A., & Hoffman, R. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00016 · Cited by 145
Self-citationTargeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium
Guo, Y., Chen, Y., Liu, X., Min, J.-J., Tan, W., & Zheng, J. H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.033 · Cited by 124
Metadata
- Authors
- Silva-Valenzuela, C. A., Desai, P. T., Molina-Quiroz, R. C., Pezoa, D., Zhang, Y., Porwollik, S., Zhao, M., Hoffman, R. M., Contreras, I., Santiviago, C. A., & McClelland, M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-04-28
- Volume
- 7
- Issue
- 23
- Pages
- 35169-35180
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2342931535
- Cited by
- 44
- References
- 1
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella. https://app.cochat.ai/papers/10.18632/oncotarget.9071
- The paper
- Silva-Valenzuela, C. A., Desai, P. T., Molina-Quiroz, R. C., Pezoa, D., Zhang, Y., Porwollik, S., Zhao, M., Hoffman, R. M., Contreras, I., Santiviago, C. A., & McClelland, M. (2016). Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella. Oncotarget. https://doi.org/10.18632/oncotarget.9071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.